Psychedelic Business Spotlight – April 29
This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.
Greg Gilman is Psychedelic Spotlight's lead content editor, as well as a contributor. His previous work has appeared in dozens of publications, including USA Today, Yahoo! News, TheWrap, MovieMaker Magazine and SyFy Wire. When he's not writing, he's the lead singer for LA-based Americana rock band Greg in Good Company. Given his experience as an artist, he's particularly interested in the intersection of psychedelics and entertainment.
This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.
Watch late psychedelic icons María Sabina and Terence McKenna in action, and catch a glimpse inside psilocybin therapy sessions.
Famed film composer returns to rock roots for a masterful, mind-melting Coachella set, and I was fortunate to catch it while tripping on LSD.
This week in psychedelic business news: Mindset Pharma files a new patent; Ehave’s MetaHealthU app seeks to cure HPPD; Wellbeing Digital Sciences contemplates a sale.
This week in psychedelic business news: The industry’s first major merger; NeonMind launches clinics; a portfolio of patents is acquired.
Researchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred reduced risk of past-year opioid dependence and abuse.
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a new CEO takes over GABA Therapeutics.
The State acknowledges proposed psilocybin services rules will incur costs that “could ultimately be passed onto clients.”
This week in psychedelic business news: TripSitter expands; Enveric files a major patent; and Psychedelic Water raises its profile.
This week in psychedelic business news: Filament Health scores 2nd psilocybin patent; a new psychedelics company emerges as one crumbles.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.